|

Bortezomib-bendamustine-melphalan Clinical Trials

1 actively recruiting trial

Also known as: High-dose melphalan

Top Sponsors

  • Uppsala University1

Indications

  • Myeloma, Multiple1
  • Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.